CATEGORY: FDA – Regulatory
Bio-Identical Hormone Risks
Why do some physicians cling so intensely to what they learned in school, when new research and new ideas so strongly encourage them to develop and practice new treatments? It is difficult to understand why so many physicians cling so[...]
Growth Hormone Deficiency: The Physical Signs
This blog begins a series of health-casts about the physical signs of the most important hormone deficiencies. We hope to help you develop your observational skills so you will notice the important physical characteristics of each hormone deficiency. Click to[...]
The Cost of Healthcare
Healthcare cost, who decides: Doctors? Insurers? Regulators? People? Please email your thoughts to [email protected]. As a general rule, discussions about the cost of health care are focused on particular treatments that you or a loved one might need or be[...]
New Female Sexual Dysfunction Drug – Addyi
Medication does exist to help women with loss of libido and sexual desire. In late 2015 there finally was a sexual dysfunction drug that was approved by the FDA for SOME women…..and can only be prescribed by doctors who have[...]
Why Doctors Use Off-label Drugs
Off-label drugs allow physicians to get around unreasonable FDA restrictions. Criticism of the FDA is an impassioned issue because they play a direct role in our health, and hold the responsibility of deciding whether a medication is approved for certain[...]
Fight FDA Restrictions on Hormone Pellets
Dr. Kathy Maupin discusses recent legislation proposed to the FDA that would limit the availability of hormone pellets that are used in her practice, as well as what you can do to help fight these decisions. Once again, the FDA[...]
Do Women Need Testosterone?
Dr. Kathy Maupin and Brett Newcomb discuss the challenges that their practice faces as they try to apply the foremost research available to help their patients feel younger through testosterone replacement therapy. Women need and use testosterone for the same[...]
How the FDA and DEA Affect Healthcare
Dr. Kathy Maupin and Brett Newcomb discuss the role that the Food and Drug Administration plays in today's medical arena. They talk about how faulty policies and business interests can often keep patients from receiving optimal and effective treatment. This[...]
Senate Bill 959
Senate Bill 959, if passed, could limit or stop our access to bioidentical hormone pellet therapy. My practice and the health and comfort of my bioidentical hormone patients depends on the availability of pellets manufactured by compounding pharmacies. The US[...]
Senate Bill 959 Part 2
Your Bio-Identical Hormone Pellets are at Risk. Act Now to Stop Senate Bill 959 Senate Bill 959 is working its way through the Senate Health Education Labor and Pensions committee. This Bill is attempting to establish the authority for the[...]